A Rapidly Progressive Cataract in a Patient with Autoimmune Hypoparathyroidism and Acute Liver and Renal Failure

Abstract

Cataract is a well-known complication of hypoparathyroidism, albeit the mechanism is obscure. The progression of cataract is typically slow in patients with idiopathic hypoparathyroidism. We describe a case of an extremely rapid evolution of typical hypocalcemic cataracts in a patient with familial autoimmune hypoparathyroidism during acute idiopathic hepatic and renal failure, while serum calcium and phosphorus were unbalanced. Physicians and ophthalmologists must be aware of cataracts developing rapidly in the setting of such metabolic derangements.

Journal

Journal ID (publisher-id): AJN

Journal ID (nlm-ta): Am J Nephrol

Journal ID (doi): 10.1159/issn.0250-8095

Title: American Journal of Nephrology

Publisher: S. Karger AG

ISSN (Print): 0250-8095

ISSN (Electronic): 1421-9670

Publication date Subscription-year: 1999

Publication date (Print): August 1999

Publication date (Electronic): 13 August 1999

Volume: 19

Issue: 4

Pages: 523-526

Affiliations

Department of ^aNephrology, ^bLiver Unit, and ^cDepartment of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Article

Publisher ID: 13493 Other ID: Am J Nephrol 1999;19:523–526

DOI: 10.1159/000013493

PubMed ID: 10460947

Copyright statement: © 1999 S. Karger AG, Basel

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Page count

Figures: 2, Tables: 1, References: 16, Pages: 4

Product

Self URI (application/pdf): https://www.karger.com/Article/Pdf/13493

Self URI (text/html): https://www.karger.com/Article/FullText/13493

Self URI (journal page): https://www.karger.com/SubjectArea/Nephrology

Categories

Subject: Case Report